Singular

✨ Next week our CTO Gustave Ronteix and our Lead Computational Biologist Lélia Polit will be attending ASCO GI in San Francisco. This is an incredible opportunity to track some of the latest developments in GI cancer drug development and cancer care. 🔮 Orakl Oncology will be sharing its latest results and showcasing the clinical relevance of its patient avatar platform for derisking drug discovery. ▪️ We’re presenting 2 posters with new data and results. ▪️ A major focus of our work features the translational power of Orakl Oncology’s patient avatars – and the role they can play in advancing the next generation of cancer therapeutics. → If you are interested in knowing more, please reach out to meet in sunny San Francisco!

🚀 We are excited to announce our first participation in the J.P. Morgan Healthcare Conference in San Francisco next week!    We can't wait to be part of the largest event in the world focused on life sciences investment and business development.     We look forward to engaging in meaningful discussions with key players in the BioTech ecosystem, especially in oncology, forging new partnerships, and exploring the latest developments in drug development and life sciences.    At Orakl Oncology, we are at the forefront of innovation and research in oncology, integrating patient tumors and clinical data to create AI-powered tumor avatars that accelerate and de-risk drug discovery.  🔎 Do not hesitate to visit our website www.orakl-oncology.com to know more about our products, O-Predict and O-Validate!    ✨ Join us and meet our co-founders Fanny Jaulin, PhD, CEO, and Diane-Laure Pagès, COO, who will be delighted to connect with you throughout the week!

Heading to #JPM2025? 🧬 Basecamp Research’s Co-founder and CEO Glen Gowers, Chief Commercial Officer Anupama Hoey, CTO Phil Lorenz and new Chief Scientific Officer Jonathan (John) Finn will be there, meeting with our existing partners and exploring new collaborations. We’re building momentum on our mission to solve the most pressing challenges in life sciences. Just this week, we announced: - A new Boston lab, led by our new CSO John Finn - A 10x acceleration in global data collection over the past three months - Expanded compute infrastructure powering new massive biological foundation models These advancements position us to tackle biology’s most complex challenges—starting with programmable genome edits. We’re actively partnering on this and other programs addressing complex design challenges. Let’s connect! 📅 If you’d like to meet in San Francisco, contact us at explore@basecamp-research.com To read a selection of recent coverage see links below in comments.

Basecamp Research is kicking off 2025 with a series of announcements. We're excited to welcome Jonathan (John) Finn as our new CSO, we have also established our first US office and lab in Boston and we've built one of Europe's largest industrial supercomputers with NVIDIA accelerated computing. You can read more in Darren Incorvaia's piece today in Fierce Biotech and our official announcement. (Links to both below in comments). #biotech #AI #JPM2025

Beyond proud of the Synthflow AI team—what we’ve accomplished this year is truly off the charts. - 20+ insanely talented people - 15x revenue growth - Leading no-code platform for voice AI agents - Raised 2 funding rounds It’s been a wild ride fueled by persistence and hard work. Every new tech wave comes with a thick haze of noise, but at Synthflow we’re focused on building real, long-term value for our customers. That’s tougher, but it’s the right approach—and we’re just getting started. 2025 is going to be huge. Oh, and we’re hiring: 2 Account Executives and 1 SDR asap who’ll work directly with me. Don’t miss the chance to join one of the fastest-growing companies in the gen AI era. Apply here: https://lnkd.in/eUxZbM-z

I’m humbled to feature In today’s « la Relève » of Les Echos. It traced the founding of Typology, going all the way back from Foshan my hometown in China, to the kind baker family that adopted me in Vitry-sur-Seine, and then all the ups & downs 🎢 of my early entrepreneurial life, Myfab and Made.com. 👉 https://lnkd.in/ePvdt4aP Merci Virginie Jacoberger-Lavoue 🙏

A quick Vibe.co year-in-review before everyone gets too deep into the company party egg nog... and what a year it's been! 🚀 From the bottom of the entire Vibe.co team's nerdy little hearts, a massive THANK YOU to all of our clients, partners, and peers for our best year yet. Stay tuned for what's next, and happy holidays! 💫 #VibeWrapped

✨ 𝟮𝟬𝟮𝟰: 𝗔 𝘆𝗲𝗮𝗿 𝘀𝗵𝗮𝗽𝗲𝗱 𝗯𝘆 𝗬𝗢𝗨! 💙 As we close out 2024, we want to say thank you to the incredible Heyflow community – our customers, champions, and partners. Their creativity and passion inspire us every day, and their feedback has driven every major improvement based on two core pillars: ✔️ Faster performance, enhanced speed, and stronger security ✔️ Game-changing features built with Heyflow Champions, our community hub But don’t just take our word for it – swipe through our year in numbers! 👇📊 🚀 From milestones to impact, these visuals tell the story of what we accomplished together. 𝗪𝗵𝗮𝘁’𝘀 𝗰𝗼𝗺𝗶𝗻𝗴 𝗶𝗻 𝟮𝟬𝟮𝟱? We’re doubling down on making lead generation easier, smarter, and more customizable than ever before, so stay tuned! Here’s to a 2025 filled with growth, success, and new possibilities – together. 🙌

Thank you to everyone who has voted for our #SXSWLondon 2025 session! If you haven't, there is still a day left (until 11:59, Dec. 19) to help put Basecamp Research on stage at the first European edition of the legendary tech, health, and culture conference. You can vote in the link below (you'll need to log in to vote): 👇 https://bit.ly/3VDFBn8 (you can also find our session by searching for "digital twin" Glen Gowers 👉 Earth's Digital Twin: What AI needs to unlock the Medicine of the Future Thanks again! #sxswlondon2025 #biotech #AI #healthcare

C’est officiel : notre podcast est lancé ! 🎙️ Pour ce premier épisode, "CGP : le retour en force des enveloppes bancaires", notre CEO Benjamin Chemla s’entoure de Charlotte THAMEUR, Head of Business Development chez Shares, et de Guillaume Simonin, partenaire de Shares, pour aborder un sujet au cœur des enjeux actuels des CGP. Au programme : - La genèse et les ambitions de Shares Pro, notre plateforme conçue pour accompagner les CGP dans un environnement en pleine évolution. - Un focus sur les enveloppes bancaires : pourquoi reviennent-elles sur le devant de la scène et qu’est-ce que cela signifie pour les investisseurs ? 📺 Disponible dès maintenant sur YouTube et toutes vos plateformes de podcast favorites - https://lnkd.in/ezVUQ8mz 💡 Un nouveau rendez-vous toutes les deux semaines pour explorer ensemble les tendances et solutions qui transforment l’investissement, que vous soyez CGP ou investisseur particulier. Ce contenu ne constitue pas un conseil en investissement. Les performances passées ne préjugent pas des performances futures. Risque de perte en capital.